Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
NCT ID:
NCT04875533
Pre Assignment Details:
A total of 1425 participants were randomized to receive either 20vPnC/saline (713 participants) or 13vPnC/PPSV23 (712 participants); 2 participants in the 20vPnC/saline group and 2 participants in the 13vPnC/PPSV23 group were not vaccinated, therefore, a total of 1421 participants were vaccinated and included in the summary..
Recruitment Details:
Participants 60 years of age and above were recruited into this study to received either Pneumococcal Conjugate Vaccine (20vPnC)/saline or 13-valent pneumococcal conjugate vaccine (13vPnC)/23-valent pneumococcal polysaccharide vaccine (PPSV23).
Study:
NCT04875533
Study Brief:
Results Section:
NCT04875533